Bracco buys Merck out of contracst media joint venture
This article was originally published in Clinica
Executive Summary
German company Merck and Italy's Bracco have ended their 70-year alliance with a $900 million agreement that sees Merck depart from the contrast agent market. Bracco will buy back Merck's 50% share in the imaging joint venture between the two companies and will in turn sell its 50% share in the laboratory business to Merck. Merck will concentrate on its pharmaceutical operations.